← Search

Excel · study · 2026

Gene expression profiling of H23 lung adenocarcinoma cells treated with sotorasib and linsitinib alone or in combination

Listed in NCBI GEO

KRAS G12C inhibitors have improved the treatment of KRAS G12C-mutant lung cancer; however, adaptive resistance limits their long-term efficacy.

Description

To investigate the transcriptional effects of combined KRAS and IGF1R inhibition, we performed RNA sequencing of the KRAS G12C-mutant lung adenocarcinoma cell line H23 following treatment with sotorasib, linsitinib, or their combination. This dataset provides genome-wide gene expression profiles associated with single-agent and combination treatments and may facilitate the identification of molecular mechanisms underlying the enhanced antitumor effects of combined KRAS and IGF1R inhibition.

Links

Where it is published

Documentation and papers

Topics

From keywords
Life Sciences
Inferred from text
Cancer 75% · RNA sequencing 75% · Sequencing 75%
Provenance · 1 source records, 10 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE34264615 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[disease].local:disease:cancerenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:expression-profiling-by-high-throughput-sequencingsource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[modality].local:modality:rna-seqenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[modality].local:modality:sequencingenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[organism].NCBITaxon:9606source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title